Skye Bioscience, Inc. Share Price & Technical Analysis
SKYE · $0.83 (+16.90%)
Healthcare / Biotechnology
$0.83
+16.90%
Skye Bioscience, Inc., a clinical-stage biotechnology company, focuses on developing molecules that modulate G-protein-coupled receptors (GPCRs) to treat obesity, overweight, and metabolic diseases. Its lead product candidate is nimacimab, a peripherally restricted negative allosteric modulating antibody targeting cannabinoid receptor 1, a key GPCR involved in metabolic regulation. The company was…
Price chart
Seasonality
May has 2 positive and 3 negative years (last 5 years shown)
-11% return in May, -1% avg return in past 3 year May month.
5% return in 2026, 92% avg return in past 3 years.
Swipe sideways to see all months →
| Jan | Feb | Mar | Apr | May | Jun | Jul | Aug | Sep | Oct | Nov | Dec | Yr | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 26 | 43% | -30% | -25% | 29% | -11% | – | – | – | – | – | – | – | 5% |
| 25 | 10% | -15% | -45% | 38% | -9% | 110% | -12% | 3% | 11% | -62% | -13% | -38% | -22% |
| 24 | 54% | 256% | 5% | -9% | -12% | -32% | -28% | 19% | -37% | 33% | -15% | -38% | 197% |
| 23 | 113% | -11% | -38% | -24% | 19% | 49% | 16% | -27% | -2% | -55% | -6% | 69% | 100% |
| 22 | 9% | -23% | 3% | 0% | 3% | -7% | 5% | -24% | -7% | -3% | -10% | -11% | -66% |
Monthly return % by calendar month · historical pattern, not a forecast
Weak · Downtrend · Uptrend
Skye Bioscience, Inc., a clinical-stage biotechnology company, focuses on developing molecules that modulate G-protein-coupled receptors (GPCRs) to treat obesity, overweight, and metabolic diseases. Its lead product candidate is nimacimab, a peripherally restricted negative allosteric modulating antibody targeting cannabinoid receptor 1, a key GPCR involved in metabolic regulation. The company was formerly known as Emerald Bioscience, Inc. and changed its name to Skye Bioscience, Inc. in January 2021. Skye Bioscience, Inc. is headquartered in San Diego, California.
Full AI Q&A, portfolio tracking, and live alerts in the app.
Key metrics
Market cap
$29.54M
P/E ratio
—
52W high
$5.75
52W low
$0.57
Volume
2,33,502
Beta
3.02
Related stocks in Healthcare
Merck & Co Inc Cedear (5…
₹32,900
Abbott Laboratories Cede…
₹30,500
Eli Lilly And Company Ce…
₹25,540
Unitedhealth Group Inc C…
₹17,200
₹6,600
Frequently asked questions
- What is Skye Bioscience, Inc. share price today?
- Skye Bioscience, Inc. (SKYE) last traded around $0.83 on StockPro. Prices refresh every few minutes during market hours.
- What technical signals does SKYE have?
- StockPro monitors breakouts, volume spikes, EMA reversals, and momentum for SKYE. Download the app for real-time alerts.
- How can I analyze Skye Bioscience, Inc. stock?
- Use the price chart, seasonality heatmap, key metrics, and AI insight on this page. For portfolio tracking and push alerts, download StockPro on Android or iOS.